Thank you for visiting Gilead.com. Please explore this section for the latest news about Gilead, our groundbreaking research and our therapeutics.

Please see Gilead-at-a-Glance to learn more about the company and our portfolio of products.

Sign-up to receive email alerts whenever new company information is posted to the site.

Recent News

February 2, 2012
Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results

January 26, 2012
Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012

January 24, 2012
Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV

January 18, 2012
U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV

January 18, 2012
Roy D. Baynes, MD, PhD, to Join Gilead Sciences as Senior Vice President, Oncology Therapeutics

January 17, 2012
Gilead Sciences Completes Acquisition of Pharmasset, Inc.

January 12, 2012
Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc.

January 6, 2012
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period

January 5, 2012
Gilead Sciences to Present at the 30th Annual JPMorgan Healthcare Conference on Monday, January 9